1. Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Issue 3 (20th December 2019) Authors: Sone, Hirohito; Kaneko, Tatsuroh; Shiki, Kosuke; Tachibana, Yoshifumi; Pfarr, Egon; Lee, Jisoo; Tajima, Naoko Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗